MedPath

Effect of Talisadi Arka and Churna in Allergic Respiratory Tract Disease

Phase 2
Conditions
Health Condition 1: J988- Other specified respiratory disorders
Registration Number
CTRI/2023/07/055367
Lead Sponsor
Dean and Principal of Parul Institute of Ayurved
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1) Patients of either gender with age group 20-65 Years (both years inclusive).

2) Elevated level of IGM &IGE mild and moderate

3) Patients having clinical features of Allergic Rhinitis

4) Patients having clinical features of Bronchial asthma

Exclusion Criteria

1) Known case of any chronic and severe systemic disorder including IHD, CVA, uncontrolled

Hypertension, uncontrolled diabetes, CRF, Active Malignancy Disease.

2) Pregnant and lactating females.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Assessment on the basis of gradation criteria of bronchial asthmaTimepoint: At Baseline visit, every 15th day up to 90 days
Secondary Outcome Measures
NameTimeMethod
Assessment on the basis of AEC, CBC, LDH, CRP, IGM & IGETimepoint: At Baseline visit and on 90th day
© Copyright 2025. All Rights Reserved by MedPath